A Nature Communications paper reports that historical and circulating Oropouche strains reach neurons in human forebrain organoids at every stage of differentiation. Set against Zika virus, neuroinfection runs higher in the organoids and also in neonatal mice. The paper says clinics have tied recent strains to congenital infection. It does not treat the organoid and mouse findings as a measure of disease in human pregnancy. News pages found for other Oropouche organoid experiments belong to different papers.
The Nature Communications article says historical and circulating Oropouche strains reach neurons in human forebrain organoids at every stage of differentiation. The comparison it draws is with Zika virus. In that comparison, Oropouche shows a higher capacity for neuroinfection in the organoids.[1]
The same paper reports neuroinfection in neonatal mice, again higher than in the Zika comparison. It also says clinics have tied recent strains to congenital infection and to neurodevelopmental disease. The organoid and mouse findings are not presented as a measure of disease in human pregnancy.[1]
The article says clinics have tied recent strains to congenital infection. It also says the organoid findings and the neonatal-mouse findings are not a measure of disease in human pregnancy. That limit is part of the result, not a later addition. The organoid result, the neonatal-mouse result and the refusal to generalize them to human pregnancy are all inside the one Nature Communications paper. The other organoid articles remain separate experiments.[1]
